Trials / Unknown
UnknownNCT05901376
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection: a Diagnostic Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 280 (estimated)
- Sponsor
- King Chulalongkorn Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to compare specific microRNA levels from the plasma of gastric cancer patients and healthy volunteers to see if there is an upregulated expression in gastric cancer patients. The main question it aims to answer is: \- Can microRNAs be effectively used as diagnostic biomarkers for gastric cancer? Participants will be asked for their consent to obtain 5 cc of blood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MicroRNA | MiR-20a, MiR-21, MiR-106b, MiR-199a, MiR-223 |
Timeline
- Start date
- 2023-04-25
- Primary completion
- 2025-01-01
- Completion
- 2025-06-01
- First posted
- 2023-06-13
- Last updated
- 2023-06-13
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05901376. Inclusion in this directory is not an endorsement.